Lin J - Search Results

1

[Optimizing the methods of whole lung cancer RNA-loaded dendritic cells].

Wang K, Wu Y, Zhou Q, Xu C, Lin J, Yang X, Huang S. Wang K, et al. Among authors: lin j. Zhongguo Fei Ai Za Zhi. 2005 Dec 20;8(6):489-94. doi: 10.3779/j.issn.1009-3419.2005.06.01. Zhongguo Fei Ai Za Zhi. 2005. PMID: 21208534 Free article. Chinese.

2

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.

Zhang X, Zhang S, Yang X, Yang J, Zhou Q, Yin L, An S, Lin J, Chen S, Xie Z, Zhu M, Zhang X, Wu YL. Zhang X, et al. Among authors: lin j. Mol Cancer. 2010 Jul 13;9:188. doi: 10.1186/1476-4598-9-188. Mol Cancer. 2010. PMID: 20624322 Free PMC article.

3

[Analysis of Differentially Expressed Proteins in Self-Paired Sera of Advanced Non-small Cell Lung Cancer Patients Responsive to Gefinitib.].

Yang X, Zhang X, Yang J, Huang Y, Guo A, Lin J, An S, Tang H, Cheng S, Huang Y, Wu Y. Yang X, et al. Among authors: lin j. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):765-9. doi: 10.3779/j.issn.1009-3419.2009.07.018. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719152 Free article. Chinese.

4

[RRM1 expression in tissue microarray and prognosis analysis in non-small cell lung cancer].

Liao R, Lin J, Qiao G, Luo X, Yang J, Huang Y, Wu Y. Liao R, et al. Among authors: lin j. Zhongguo Fei Ai Za Zhi. 2006 Oct 20;9(5):423-7. doi: 10.3779/j.issn.1009-3419.2006.05.06. Zhongguo Fei Ai Za Zhi. 2006. PMID: 21176463 Free article. Chinese.

5

[The abnormity and clinical value of tyrosine kinase signaling pathway in lung adenocarcinoma].

Wu YL, Lin JY, Yang XN, Qiao GB, Wang K, Chen G. Wu YL, et al. Zhonghua Yi Xue Za Zhi. 2004 Jun 17;84(12):992-6. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15312532 Chinese.

6

[Expressions of E-cadherin in non-small cell lung cancer and it correlation with prognosis].

Qiao GB, Wu YL, Ou W, Yang XN, Zhong WZ, Lin JY, Zhao J, Xie D, Guan XY. Qiao GB, et al. Among authors: lin jy. Zhonghua Wai Ke Za Zhi. 2005 Jul 15;43(14):913-7. Zhonghua Wai Ke Za Zhi. 2005. PMID: 16083620 Chinese.

7

[Gefitinib target treatment in non-small cell lung cancer].

Wu YL, Yang JJ, Lin JY, Huang YJ, Liao RQ, Huang YS, Zhou Q, Xu CR, Wang Z. Wu YL, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):98-102. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17445469 Clinical Trial. Chinese.

8

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, Zhou Q, Xu CR, Wang Z, Zhang GC, Mok T. Wu YL, et al. J Thorac Oncol. 2007 May;2(5):430-9. doi: 10.1097/01.JTO.0000268677.87496.4c. J Thorac Oncol. 2007. PMID: 17473659 Free article.

9

[Relationship of the curative effects of gefitinib on non-small cell lung carcinoma to gender and to epithelial growth factor receptor status].

Xu CR, Lin JY, Wang Z, Zhou Q, Zhang GC, Wang K, Yang XN, Chen G, Yang JJ, Huang YJ, Liao RQ, Wu YL. Xu CR, et al. Zhonghua Yi Xue Za Zhi. 2006 Oct 10;86(37):2606-10. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17198584 Chinese.

10

The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer.

An SJ, Chen ZH, Lin QX, Su J, Chen HJ, Lin JY, Wu YL. An SJ, et al. Among authors: lin qx, lin jy. BMC Cancer. 2009 May 12;9:144. doi: 10.1186/1471-2407-9-144. BMC Cancer. 2009. PMID: 19435508 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,971 results

Search Page

Filters